AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Exemestane in South Africa
5 products registered with SAHPRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EXMA | 45/21.12/0729 | Pharmaplan (Pty) Ltd | suspended | 19 Dec 2023 |
| EXEMESTANE 25 mg ACTIVO | 46/21.12/0157 | Activo Health (Pty) Ltd | active | 1 Jan 1900 |
| EXICAN | 45/21.12/0425 | Ranbaxy (SA) (Pty) Ltd | active | 1 Jan 1900 |
| AROMASIN 25 mg | 35/21.12/0011 | Pfizer Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| EQUISIN | 45/21.12/0908 | Equity Pharmaceutical (Pty) Ltd | active | 1 Jan 1900 |
Exemestane — SAHPRA Registration Details
SAHPRA (South Africa) has 5 registered products containing Exemestane, of which 4 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Exemestane registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.